They indicated that elevated Spry1 in ERMS cells associated with hyperactive ERK signaling is caused by oncogenic RAS mutations which is frequent in ERMS but absent in ARMS. The gene discussed is SPRY1; the disease is alveolar rhabdomyosarcoma.